Int J Oncol 42: 873-880, 2013; DOI: 10.3892/ijo.2013 DOI: 10.3892/ijo. .1761 Following the publication of this article, an interested reader drew to our attention an anomaly associated with the presentation of Figs. 2 and 3. Essentially, there was a direct duplication of certain of the western blotting data between Fig. 2 (the E-cadherin and Actin data) and Fig. 3C (the Zyxin and Actin data).
After having re-examined our original data, we realize that we inadvertently duplicated the data from Fig. 2 in Fig. 3C (the Zyxin and Actin data).
A corrected version of Fig. 3C (containing the true Zyxin and Actin data), and, by natural process, also of Fig. 6 , are presented below, in which the Zyxin data in Figs. 3C and 6 are now correctly shown. Since the Zyxin data was a control for the siZyxin knockout of HOC313, this error did not affect the results of the Rho family analysis in this study. We sincerely apologize for this mistake, and thank the reader of our article who drew this matter to our attention. Furthermore, we regret any inconvenience this mistake has caused. . Analysis of Rho family proteins by western blotting. Rho family small GTPases involved in cell migration and invasion, such as RhoA, Rac1 and CDC42, were examined. There was no significant difference in expression of RhoA, but expressions of Rac1 and CDC42 were slightly reduced in Zyxin siRNA-treated cells.
